Explore 3 Stock Ideas & Industry Insights Download Free Report

Bioelectronics Corp

Company price
0.0003 USD 0.00 ( 50.00%)
Last update at 2026-11-20T16:53:00Z
VOLUME
3000000
Market Cap
9.88M

Momentum Score

…

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

BioElectronics Corp develops and sells non‑invasive, low‑level electrical stimulation devices for consumer and select clinical use to manage pain. Long‑term drivers are demand for non‑opioid pain options, expansion of direct‑to‑consumer and international sales, and product development, which may support its long‑term outlook.
Key risks include limited public disclosure and thin trading on the Pink market, reliance on a narrow product portfolio with regulatory and execution uncertainty, and competition from larger device makers and pharmacologic alternatives.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
1.61M
Revenue Per Share
-
Gross Profit TTM
0.80M
Debt / Equity
-0.89
ROE
-
Net Debt
15.52M
ROCE
10.02%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.93M -0.72M -0.78M - -
Net income -0.93M -0.72M -0.78M - -
Gross profit 0.36M 0.47M 0.49M - -
Ebit - -0.44M -0.57M -0.14M -1.03M
Ebitda -0.39M -0.27M -0.34M - -
Depreciation and amortization - 0.17M 0.23M - -
Operating income -0.39M -0.27M -0.34M - -
Other operating expenses 0.89M 0.99M 1.05M - -
Interest expense 0.54M 0.45M 0.44M 0.00M 0.00M
Income tax expense - -0.17M -0.23M - -
Total revenue 0.50M 0.71M 0.71M - -
Total operating expenses 0.76M 0.74M 0.83M - -
Cost of revenue 0.13M 0.25M 0.22M - -
Total other income expense net -0.54M -0.45M -0.44M - -
Net income applicable to common shares - - - -0.29M -1.16M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.04M 0.14M 0.25M - -
Other current assets - - 0.00M - -
Total liab 17.45M 16.62M 16.01M - -
Total stockholder equity -17.41M -16.48M -15.76M - -
Other current liab 0.79M 0.78M 0.93M 0.58M 1.00M
Common stock 23.34M 23.34M 23.34M 24.38M 24.13M
Retained earnings -40.74M -39.81M -39.09M -38.31M -38.25M
Cash 0.01M 0.00M 0.05M - -
Total current liabilities 3.96M 4.09M 3.81M 5.93M 8.84M
Current deferred revenue 0.10M 0.21M 0.25M - -
Net debt 15.52M 14.83M 14.04M - -
Short term debt 2.04M 2.30M 1.90M - -
Short long term debt total 15.53M 14.83M 14.09M - -
Other stockholder equity - 0.00M -23.34M -1.19M -1.01M
Total current assets 0.04M 0.14M 0.25M 0.08M 0.43M
Net tangible assets - - - -15.12M -15.12M
Net receivables 0.00M 0.10M 0.08M 0.06M 0.16M
Inventory 0.03M 0.04M 0.13M 0.03M 0.15M
Accounts payable 1.03M 0.80M 0.74M 0.65M 0.73M
Accumulated other comprehensive income - - 23.34M - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Change to liabilities - - - -0.51M 0.25M
Net borrowings - - - 0.32M 0.72M
Total cash from financing activities 0.17M 0.30M 0.52M 0.21M 0.59M
Change to operating activities - - - - 0.01M
Net income -0.93M -0.72M -0.23M -0.29M -1.16M
Change in cash 0.00M -0.04M 0.04M -0.11M 0.06M
Begin period cash flow 0.00M 0.05M 0.00M - -
End period cash flow 0.01M 0.00M 0.05M - -
Total cash from operating activities -0.16M -0.34M -0.48M -0.32M -0.53M
Change to inventory 0.01M 0.09M -0.10M 0.13M -0.05M
Change to account receivables 0.09M -0.07M -0.02M 0.11M 0.01M
Other cashflows from financing activities - 0.30M 0.52M -0.11M -0.13M
Change to netincome - - - 0.25M 0.42M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.23M -0.11M -0.06M - -
Other non cash items 0.54M 0.50M -0.19M - -
Free cash flow -0.16M -0.34M -0.48M - -

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
BIEL
Bioelectronics Corp
0.00
50.00%
0.00 - - 6.14 -
ABT
Abbott Laboratories
-0.20
0.19%
103.00 25.97 17.24 3.57 3.20
MDT
Medtronic PLC
-0.59
0.59%
100.02 26.60 15.87 3.35 2.08
SYK
Stryker Corporation
-
-%
310.00 29.23 16.86 4.18 4.51
SEMHF
Siemens Healthineers AG
-
-%
48.34 39.57 21.32 3.01 3.29

Profile*

Bioelectronics Corp

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

4539 Metropolitan Court, Frederick, MD, United States, 21704

301 874 4890

Name Title Year Born
Mr. Andrew J. Whelan Founder 1942
Ms. Kelly A. Whelan CEO, Pres, Treasurer & Exec. Director NA
Mr. Keith E. Nalepka VP of Sales & Marketing and Exec. Director 1974
John R. Martinez Sec. & VP of Engineering NA
Ms. Kelly A. Whelan CEO, President, Treasurer & Executive Director NA
Mr. Keith E. Nalepka VP of Sales & Marketing and Executive Director 1974
Mr. John R. Martinez Secretary & VP of Engineering NA
Mr. John R. Martinez Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…